1. Home
  2. NBTB vs QURE Comparison

NBTB vs QURE Comparison

Compare NBTB & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$46.44

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo uniQure N.V.

QURE

uniQure N.V.

HOLD

Current Price

$25.59

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
QURE
Founded
1856
1998
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
NBTB
QURE
Price
$46.44
$25.59
Analyst Decision
Buy
Buy
Analyst Count
2
13
Target Price
$51.00
$56.25
AVG Volume (30 Days)
211.5K
2.1M
Earning Date
01-26-2026
02-26-2026
Dividend Yield
3.19%
N/A
EPS Growth
12.12
N/A
EPS
3.33
N/A
Revenue
$678,339,000.00
$15,751,000.00
Revenue This Year
$14.85
N/A
Revenue Next Year
$6.02
$142.93
P/E Ratio
$13.93
N/A
Revenue Growth
21.71
N/A
52 Week Low
$37.31
$7.76
52 Week High
$49.18
$71.50

Technical Indicators

Market Signals
Indicator
NBTB
QURE
Relative Strength Index (RSI) 65.66 59.41
Support Level $41.87 $24.37
Resistance Level $44.86 $28.48
Average True Range (ATR) 1.36 1.93
MACD 0.26 0.54
Stochastic Oscillator 92.38 92.25

Price Performance

Historical Comparison
NBTB
QURE

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About QURE uniQure N.V.

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Share on Social Networks: